Background Exposure to environmental tobacco smoke (ETS) has been epidemiologically linked to death from ischemic heart disease in nonsmokers. In this study, we evaluated the influence of 3 days, 3 weeks, and 6 weeks of ETS exposure on myocardial infarct size in a rat ischemia/reperfusion model.
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William W. Parmley, MD; Christopher L. Wolfe, MD Background Exposure to environmental tobacco smoke (ETS) has been epidemiologically linked to death from ischemic heart disease in nonsmokers. In this study, we evaluated the influence of 3 days, 3 weeks, and 6 weeks of ETS exposure on myocardial infarct size in a rat ischemia/reperfusion model.
Methods and Results Sprague-Dawley rats exposed to ETS (four Marlboro cigarettes per 15 minutes, 6 hours per day, 5 days per week) for 3 days (n=24), 3 weeks (n=21), or 6 weeks (n= 12) and control rats (n=24, n=21, and n=12, respectively) were subjected to 35 minutes of left coronary artery occlusion and 2 hours of reperfusion. Infarct size and risk area were determined by triphenyltetrazolium chloride and phthalocyanine blue staining, respectively. Air nicotine, carbon monoxide, and total particulates were measured during ETS exposure. Serum lipids, plasma carbon monoxide hemoglobin (COHb), nicotine, and cotinine concentrations were measured in additional groups (6 to 13 rats each) exposed to 3 days, 3 weeks, or 6 weeks of ETS and controls. Average air nicotine, E nvironmental tobacco smoke (ETS), the tobacco combustion products inhaled by nonsmokers in the proximity of burning tobacco, is hazardous because it contains high concentrations of ammonia, benzene, nicotine, carbon monoxide, and many other carcinogens and irritants.1,2 The effects of passive smoking on health have been reported to include acute effects, such as exacerbation of asthma and angina, as well as chronic effects, such as increased risk of lung cancer, respiratory tract infection, and atherosclerosis.3-6 ETS also has been linked to death from ischemic heart disease in nonsmokers. Epidemiological studies conducted by a number of investigators demonstrate approximately a 30% increase in risk of death from ischemic heart disease or myocardial infarction in nonsmokers living with smokers. 3, 4, 7, 8 Although no one has previously reported the effect of ETS exposure on myocardial infarct size, a number of studies suggest that ETS exposure adversely affects the myocardial oxygen supply-and-demand relation that would predispose the heart to develop ischemia or exacerbate preexisting ischemia. Direct or indirect exposure to tobacco smoke has been shown to increase the hemodynamic determinants of myocardial oxygen de-mand910 at the same time that it potentially reduces both myocardial blood supply and oxygen delivery by enhancing the development of coronary atherosclerosis,1011 causing coronary vasoconstriction,11'2 and reducing the oxygen-carrying capacity of blood through increased serum carboxyhemoglobin (COHb) levels.9 Furthermore, through an increase in platelet aggregation, the likelihood of coronary thrombosis is enhanced after ETS exposure.13-18 Finally, ETS exposure appears to reduce oxidative phosphorylation in cardiac cells, rendering them less capable of producing ATP. 19, 20 These changes suggest that ETS exposure not only increases the likelihood of developing an acute myocardial infarction but also may increase the amount of myocardial damage once an acute myocardial infarction has occurred.
In this study, the effects of 3 days, 3 weeks, and 6 weeks of ETS exposure on myocardial infarct size were examined in an in vivo rat model of coronary artery occlusion and reperfusion. In addition, we examined the effects of ETS exposure on serum lipids, bleeding time, plasma COHb, nicotine, and cotinine.
housed in a room maintained at a constant temperature and kept on a 12-hour light-dark cycle. The 3-day study included two groups: group ETS-3 days (n=24) was exposed to sidestream smoke from Marlboro filter cigarettes (four cigarettes per 15 minutes, 6 hours per day, for 3 days) with a smoking machine (RM 1/G, Heinr Borgwald GmbH, Hamburg, Germany). At the end of each day, the smoking machine was turned off and the ventilation system of the BioClean chamber turned on to rapidly reduce the ETS level in the exposure chamber. The control animals (n=24) were in a separate room breathing clear air for 3 days. The 3-week and 6-week studies each included two groups: group ETS-3 weeks (n=21) and group ETS-6 weeks (n= 12) were exposed to the same dose of ETS (6 hours per day, 5 days per week) for 3 or 6 weeks; the control animals (n=21 and n= 12, respectively) were in a separate room breathing clear air for 3 or 6 weeks. All rats were fed a regular diet.
Rat Model of Acute Myocardial Ischemia and Reperfusion
A rat model of left coronary artery occlusion and reperfusion was used as previously described.22-24 After induction of anesthesia (pentobarbital, 40 mg/kg IP), a tracheostomy was performed, and the animal was ventilated on a Harvard Rodent Respirator (model 683). A reversible coronary artery snare occluder was placed around the proximal left anterior descending coronary artery via a midline sternotomy. After the snare occluder was visually tested during a brief period of occlusion and reperfusion, the thoracotomy was closed. The animals were then subjected to the experimental protocol.
Experimental Protocol
All six groups (12 to 24 rats each) were subjected to 35 minutes of left coronary artery occlusion followed by 120 minutes of reperfusion. The occlusion/reperfusion protocol was performed 10 to 20 minutes after the 6-hour ETS exposure period. The bleeding time was measured before the rats were killed as described below. At the conclusion of the protocol, infarct size was measured as described below.
Infarct Sizing
Infarct sizing was performed as described previously. 25 The left coronary artery was reoccluded, and phthalocyanine blue dye was injected into the left ventricular cavity, allowing normally perfused myocardium to stain blue. The heart was then excised, rinsed of excess dye, and sliced transversely from apex to base into sections 2 mm thick. 
Histopathological Evaluation
Histological sections through the left coronary artery were made in the three control rats and three 6-week ETS-exposed rats. All sections were stained by hematoxylin and eosin (HE) and elastin van Giesen eosin (EVG) separately. Histopathological findings under the light microscope were determined by two investigators blindly.
Hematological and Biochemical Analysis
Determination of bleeding times was performed as described previously by warming the rat tail for three minutes in a normal saline bath maintained at 37°C. The tail was then removed from the bath, and a standard 1/2-cm longitudinal prick was made into the distal tail, avoiding any macroscopically obvious vessels, with a carbon steel blade. The incised tail was then immediately placed into the saline bath, which was gently agitated with a magnetic stirrer. The bleeding time was taken as the time required for blood flow in the incision to cease.
Total serum cholesterol, triglycerides, high-density lipoprotein (HDL) cholesterol, plasma COHb, nicotine, and cotinine were measured in additional rats after 3 days, 3 weeks, and 6 weeks of ETS exposure and their controls (6 to 13 rats per group). The plasma concentrations of nicotine and cotinine were determined by gas chromatography with nitrogen-phosphorus detection. 26 This method has been modified for simultaneous extraction and determination of cotinine by use of capillary gas chromatography.27 Total Table 2 ). The significant value of bE, indicates a significant dose-response relation between infarct size and the duration of ETS exposure. Infarct size was nearly doubled after 180 hours of ETS exposure, to 61+5% compared with 34±3% in the control group.
Histopathological Evaluation
There was no evidence of left coronary artery atherosclerosis on EVG and HE stain in both control rats (n-3) and 6-week ETS-exposed rats (n-3). Within the infarcted zone there was evidence of contraction band necrosis in both control and ETS-exposed rats. COHb, Nicotine, and Cotinine Levels in Plasma
As demonstrated in Figs 3 and 4 and Table 3 , COHb, nicotine, and cotinine levels in plasma significantly increased in ETS-exposed rats (bE significantly greater than zero, P<.001 for all variables) and continued to increase over time in a dose-dependent manner (bE, significantly greater than zero, P<.001) in ETS-exposed animals compared with controls. There was a slight increase in COHb over time in the control rats (P for b,=.025), but change was much less than in the ETSexposed rats. There was no change over time in plasma nicotine or cotinine in the control rats, with the levels below the level of detection.
Alterations in Lipids
As demonstrated in Table 4 , the average serum total cholesterol, HDL cholesterol, and triglycerides did not differ significantly between ETS-exposed and control 6- 
Bleeding Times
The bleeding times in the ETS-exposed rats were significantly shortened (P for bE=.002) compared with their respective control groups (Table 3 and Fig 5) . There was a similar reduction in bleeding time in all ETS-exposed rats, regardless of duration of ETS exposure (P for bEt=.215). 
Discussion
Epidemiological studies3,4'7-28 concluded that heart disease is an important consequence of exposure to ETS and estimated that the excess risk of heart disease for nonsmokers living with smokers was 30% and that the public health burden from ETS exposure is likely to be much greater for heart disease than for lung cancer. Our results demonstrate that exposure to passive smoking significantly increases myocardial infarct size in a rat model of ischemia and reperfusion, with longer ETS exposure producing a larger effect on infarct size. ETS exposure also decreases bleeding time regardless of the length of ETS exposure. There were positive correlations between the infarct size and air nicotine, carbon monoxide, total particulate concentrations, and plasma COHb, nicotine, and cotinine levels.
Of the thousands of chemicals in ETS, those that are suspected to contribute to passive smoking-induced cardiovascular disease include nicotine, carbon monoxide, polycyclic aromatic hydrocarbons, and tobacco glycoproteins. The present study showed that air nicotine, carbon monoxide, and total particulate concentrations increased with ETS exposure and that this increased exposure in air led to a continuous buildup of plasma COHb, nicotine, and cotinine levels in ETS-exposed rats. Possible mechanisms whereby these changes could increase infarct size are described below.
Coronary Hemodynamics and Coronary Vasospasm
Exposure to cigarette smoke alters hemodynamics, resulting in an increase in myocardial oxygen demand. Previous investigators have shown that direct'O or indirect9 exposure to tobacco smoke increases the resting heart rate, systolic and diastolic blood pressure, ratepressure product, cardiac output, and maximal first derivative of left ventricular pressure (LV dP/dt).10 These effects are probably secondary to adrenergic stimulation by nicotine.1" There is also evidence that ETS has the potential to reduce myocardial oxygen supply by atherosclerotic narrowing of the coronary arteries, by vasoconstriction of the coronary arteries, and by a reduction in the oxygen-carrying capacity of the blood through the formation of COHb. A large number of clinical and experimental studies demonstrate that chronic exposure to ETS has the potential to cause atherosclerotic narrowing of coronary arteries.3,6,29 Furthermore, acute exposure to cigarette smoke causes coronary vasoconstriction through nicotine activation of the sympathetic nervous system and a-adrenergic stimulation1"30 in patients,10"' an effect that can be prevented by calcium blockers and nitroglycerin.12 ETS also causes an increase in COHb caused by exposure to carbon monoxide.9 The combined effect of reduced oxygen-carrying capacity, presumed coronary vasoconstriction, and increased rate-pressure product resulted in a decrease in anginal threshold in chronic stable angina patients who were exposed to ETS.931 A recent clinical study32 concluded that smoking appears ) for each rat group. C-3d indicates control group for 3 days; ETS-3d, exposure to environmental tobacco smoke (ETS) for 3 days (18 hours); C-3w, control group for 3 weeks; ETS-3w, exposure to ETS for 3 weeks (90 hours); C-6w, control group for 6 weeks; and ETS-6w, exposure to ETS for 6 weeks (180 hours). Values are mean±SEM.
to be the major risk factor associated with coronary vasospasm in patients without significant angiographic coronary stenosis. Increased Production of Oxygen Free Radicals and Endothelial and Myocardial Cell Injury An experimental study33 indicated that exposing rats to a low concentration of cigarette smoke increased myocardial sensitivity to ischemia/reperfusion injury and that a free radical mechanism might participate in this injury. Oxygen free radicals are known to produce damage in many biological tissues. The oxygen free radical-producing activity of polymorphonuclear leukocytes is increased by cigarette smoking. 34 The results suggested that the increased generation of oxygen free radicals by polymorphonuclear leukocytes might be responsible for Nicotine has been shown to inhibit the in vitro release of prostacyclin from the rings of rabbit or rat aorta and human veins. The suggested mechanism is the inhibition of prostacyclin synthesis through the inhibition of cyclooxygenase. Nicotine could also affect platelets by releasing catecholamines, which lead to increased thromboxane A2.30 Passive smoking also increases blood viscosity and hematocrit because of relative hypoxia induced by chronic carbon monoxide exposure.30 Clinical studies41,42 also showed that after abstention from chronic cigarette smoking, the blood thrombogenic factors and hemorheological parameters will be normalized.
Catecholamine Release and Arrhythmogenesis
A clinical study43 demonstrated that smoking-associated increments in mean (±SEM) plasma norepinephrine (227±23 to 324±39 pg/mL, P<.01) and epinephrine (44±4 to 113 ± 27 pg/mL, P<.05) and smoking-associated increments in pulse rate, blood pressure, blood glycerol, and blood lactate/pyruvate ratio were prevented by adrenergic blockade. Therefore, it can be concluded that smoking-associated increments in these hemodynamic and metabolic variables are mediated through adrenergic mechanisms. Cigarette smoking can lead to catecholamine release by nicotine. Increased circulating concentrations of catecholamines enhance platelet adhesiveness and decrease the ventricular fibrillation threshold, which is also affected by carbon monoxide.3044 We found a higher mortality from ventricular fibrillation in ETSexposed compared with control rats (23% versus 14%). This was not statistically significant, however (P=.33). The lack of significance may be a reflection of the small numbers of rats we studied. The power of these experiments to detect a doubling of the mortality rate is only 36%.
Thus, passive smoking, including nicotine and carbon monoxide, may contribute to acute myocardial ischemia or sudden death through reduction of coronary blood flow, increasing myocardial oxygen demands, increasing oxygen free radical generation, enhancement of thrombosis, releasing catecholamines, and arrhythmogenesis. ETS 
Clinical Relevance
Previous clinical studies have demonstrated increased cardiovascular morbidity associated with cigarette smoking. In 978 patients with a first myocardial infarction, Robinson et a147 reported that the smokers had a larger infarct size as estimated by serum peak creatine kinase concentrations (1382 versus 1146 LU/L, P=.010). This study did not report on the severity of coronary disease. Multivariate analysis of possible risk factors for reinfarction identified at the time of initial infarction48 showed current cigarette smoking to be the only predictive factor (reinfarction occurred in 12.5% of smokers versus 6.3% of nonsmokers, P=.04). One other study49 that followed patients after a first acute myocardial infarction reported that the risk of nonfatal reinfarction correlated with a variety of clinical parameters, including the presence or absence of cigarette smoking. Smoking was found to increase the risk of first acute myocardial infarction in a dose-dependent manner, the risk increasing 2% to 3% for each gram of tobacco smoked daily. 50 Patients with a previous myocardial infarction44 had a significantly higher plasma carbon monoxide level after exercise in a smoking environment. The cardiac responses, including peak exercise power, time to recovery of preexercise heart rate, and expired concentration having an acute myocardial infarction but also increase of carbon monoxide, were significantly worsened by passive smoking, especially in those subjects with previous myocardial infarction. There are no previous data regarding the direct effect of passive smoking on myocardial infarct size. The present study is the first study to demonstrate that passive smoking increases experimental myocardial infarct size in rats.
Conclusions
These data indicate that exposure to passive smoking significantly increases myocardial infarct size in a rat model of ischemia and reperfusion with a dose-response relation. These results are consistent with epidemiological studies demonstrating that ETS increases the risk of heart disease death.
